Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.190
+0.050 (4.39%)
At close: Nov 20, 2026, 4:00 PM EST
1.160
-0.030 (-2.52%)
After-hours: Nov 20, 2026, 4:50 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.7 million as of November 20, 2026. It is the 40,649th most valuable company in the world and the 5,430th biggest in the United States. Its market cap has decreased by 24.26% in one year.
Market Cap
10.70M
Enterprise Value
6.04M
1-Year Change
-24.26%
Global Rank
Country Rank
#5,430 United States
Category
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.70M, a decrease of -98.31%. That is a compound annual growth rate of -51.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 8.26M | -18.67% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 8.86M |
| Radiopharm Theranostics | 8.69M |
| Phio Pharmaceuticals | 8.55M |
| IN8bio | 8.35M |
| Vistagen Therapeutics | 8.28M |
| Intensity Therapeutics | 8.25M |
| Lisata Therapeutics | 8.20M |
| CalciMedica | 8.07M |